Analyst Jason Butler of JMP Securities reiterated a Buy rating on Precigen (PGEN – Research Report), with a price target of $7.00. Jason ...

Analyst Jason McCarthy of Maxim Group maintained a Buy rating on Unicycive Therapeutics (UNCY – Research Report), with a price target of ...

Read an analysis on two dividend stocks with growth potential and inflation protection, designed to thrive in today's market ...

Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stock’s valuation and upcoming launches ...

The high-profile Asia-Pacific Economic Cooperation summit in Lima has thrust one of the world’s least popular presidents into ...

The county reported its highest detainee death count in decades, including multiple suicides that reveal deep institutional ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...

Mexico's president has lashed out at Moody’s ratings service after it downgraded the Mexican government’s debt outlook to “negative.” ...

Medicare Advantage Special Needs Plans now make up more than a quarter of all enrollments. Learn more about what they are and ...

Here's a quick guide covering all the important parts of RoN's Dorms map, including soft objective locations, loadouts, and ...

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...